Tuberculosis cutis orificialis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
Tuberculosis Cutis Orificialis | |||
[[ | {{Infobox disease | ||
| name = Tuberculosis Cutis Orificialis | |||
| image = <!-- Image removed --> | |||
| caption = <!-- Image caption --> | |||
| field = [[Dermatology]] | |||
| symptoms = Ulcerative lesions at mucocutaneous junctions | |||
| complications = [[Scarring]], [[Secondary infection]] | |||
| onset = Usually in adults with advanced [[pulmonary tuberculosis]] | |||
| duration = Chronic | |||
| causes = [[Mycobacterium tuberculosis]] | |||
| risks = [[Immunocompromised]] state, [[HIV/AIDS]] | |||
| diagnosis = [[Biopsy]], [[Culture]], [[PCR]] | |||
| treatment = [[Antitubercular therapy]] | |||
| prognosis = Variable, depends on underlying [[tuberculosis]] control | |||
| frequency = Rare | |||
}} | |||
'''Tuberculosis cutis orificialis''' is a rare form of [[cutaneous tuberculosis]] that occurs when [[Mycobacterium tuberculosis]] infects the skin at the mucocutaneous junctions, such as the mouth, anus, or genitals. This condition is typically seen in individuals with advanced [[pulmonary tuberculosis]] and is considered a sign of disseminated disease. | |||
Tuberculosis cutis orificialis | |||
== | == Clinical Presentation == | ||
Patients with tuberculosis cutis orificialis present with ulcerative lesions at the mucocutaneous junctions. These lesions are often painful and may bleed. The condition is more common in adults and is associated with a high bacterial load in the body. | |||
== | == Pathophysiology == | ||
The disease occurs when [[Mycobacterium tuberculosis]] spreads from an internal focus, such as the lungs, to the skin. The bacteria reach the skin through the bloodstream or lymphatic system and establish infection at sites where the skin meets mucous membranes. | |||
== | == Diagnosis == | ||
Diagnosis of tuberculosis cutis orificialis involves a combination of clinical examination and laboratory tests. A [[biopsy]] of the lesion can reveal granulomatous inflammation, and [[culture]] or [[polymerase chain reaction (PCR)]] can confirm the presence of [[Mycobacterium tuberculosis]]. | |||
== | == Treatment == | ||
The primary treatment for tuberculosis cutis orificialis is [[antitubercular therapy]], which includes a combination of antibiotics such as [[isoniazid]], [[rifampicin]], [[ethambutol]], and [[pyrazinamide]]. Treatment duration is typically 6 to 12 months, depending on the severity and response to therapy. | |||
== | == Prognosis == | ||
The prognosis for tuberculosis cutis orificialis depends on the control of the underlying [[tuberculosis]] infection. With appropriate treatment, the skin lesions can heal, although scarring may occur. However, if the systemic disease is not controlled, the prognosis is poor. | |||
== See Also == | |||
* [[Cutaneous tuberculosis]] | * [[Cutaneous tuberculosis]] | ||
* [[Pulmonary tuberculosis]] | * [[Pulmonary tuberculosis]] | ||
* [[Mycobacterium tuberculosis]] | |||
== References == | |||
{{Reflist}} | |||
== External Links == | |||
* [World Health Organization - Tuberculosis](https://www.who.int/health-topics/tuberculosis) | |||
* [Centers for Disease Control and Prevention - Tuberculosis](https://www.cdc.gov/tb/) | |||
[[Category:Dermatology]] | |||
[[Category:Infectious diseases]] | |||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
Latest revision as of 21:45, 29 December 2024
Tuberculosis Cutis Orificialis
| Tuberculosis cutis orificialis | |
|---|---|
| ICD-10 | |
| ICD-9 | |
| DiseasesDB | |
| MedlinePlus | |
| eMedicine | |
| MeSH ID | |
Tuberculosis cutis orificialis is a rare form of cutaneous tuberculosis that occurs when Mycobacterium tuberculosis infects the skin at the mucocutaneous junctions, such as the mouth, anus, or genitals. This condition is typically seen in individuals with advanced pulmonary tuberculosis and is considered a sign of disseminated disease.
Clinical Presentation[edit]
Patients with tuberculosis cutis orificialis present with ulcerative lesions at the mucocutaneous junctions. These lesions are often painful and may bleed. The condition is more common in adults and is associated with a high bacterial load in the body.
Pathophysiology[edit]
The disease occurs when Mycobacterium tuberculosis spreads from an internal focus, such as the lungs, to the skin. The bacteria reach the skin through the bloodstream or lymphatic system and establish infection at sites where the skin meets mucous membranes.
Diagnosis[edit]
Diagnosis of tuberculosis cutis orificialis involves a combination of clinical examination and laboratory tests. A biopsy of the lesion can reveal granulomatous inflammation, and culture or polymerase chain reaction (PCR) can confirm the presence of Mycobacterium tuberculosis.
Treatment[edit]
The primary treatment for tuberculosis cutis orificialis is antitubercular therapy, which includes a combination of antibiotics such as isoniazid, rifampicin, ethambutol, and pyrazinamide. Treatment duration is typically 6 to 12 months, depending on the severity and response to therapy.
Prognosis[edit]
The prognosis for tuberculosis cutis orificialis depends on the control of the underlying tuberculosis infection. With appropriate treatment, the skin lesions can heal, although scarring may occur. However, if the systemic disease is not controlled, the prognosis is poor.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
- [World Health Organization - Tuberculosis](https://www.who.int/health-topics/tuberculosis)
- [Centers for Disease Control and Prevention - Tuberculosis](https://www.cdc.gov/tb/)
